香港股市 已收市

Microbot Medical Inc. (MBOT)

NasdaqCM - NasdaqCM 即時價格。貨幣為 USD。
加入追蹤清單
0.9401-0.0274 (-2.83%)
收市:04:00PM EDT
0.9699 +0.03 (+3.17%)
收市後: 05:40PM EDT

Microbot Medical Inc.

288 Grove Street
Suite 388
Braintree, MA 02184
United States
781 875 3605
https://microbotmedical.com

版塊Healthcare
行業Medical Instruments & Supplies
全職員工21

高階主管

名稱頭銜支付行使價出生年份
Mr. Harel GadotCo-Founder, President, CEO & Chairman813.82k1973
Mr. Yoseph BornsteinCo-Founder & Independent Director13.12k1959
Ms. Rachel VakninChief Financial Officer212.97k1980
Dr. Simon Sharon MBA, MScCTO & GM of Microbot Israel381.51k1961
Dr. Juan Diaz-CartelleChief Medical Officer1976
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

公司管治

截至 無 止,Microbot Medical Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。